Research Reports

Filters

Price

  • $0 - $500
  • $501 - $1000
  • $1001 - $2000
  • $2001 - $3000
  • $3000+
  • All
  •  to 
Show More

Categories

  • Automotive Manfacturing
  • Advanced Technologies
  • Vehicles
  • Aviation and Aerospace
  • Defense And Security
  • Agrochemicals
  • Feed and Animal Nutrition
  • Seeds and Others
  • Financial Services
  • Wealth Management
  • Business Services
  • Services and Hospitality
  • Human Resource
  • Advanced Materials
  • Chemicals
  • Metals and Minerals
  • Paints and Coatings
  • Yarn, Fabric and Textile
  • Consumer Electronics
  • Housewares
  • Retail
  • Personal Care
  • Energy and Resources
  • Oil and Gas
  • Nuclear Energy
  • Environment
  • Social Studies
  • Food Ingredients
  • Convinience Frozen Food
  • Beverages
  • Food Processing Equipment
  • Services
  • E-Commerce and Outsourcing
  • Pharmaceuticals
  • Medical Devices
  • Biotechnology
  • Healthcare IT
  • Animal Healthcare
  • Equipment and Machinery
  • Automation and Process Control
  • Building Materials
  • Real Estate and Construction
  • Packaging and Transport
  • Electronics
  • Sensors and Controls
  • Security Systems
  • Software
  • IT hardware and Networks
  • Internet Business
  • Media
  • Travel Services
  • Travel and Tourism
  • Water Services
  • Water Treatment
Show More

Country

  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia, Plurinational State of
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Canary Islands
  • Cape Verde
  • Catalonia
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Colombia
  • Comoros
  • Congo
  • Congo, The Democratic Republic of the
  • Cook Islands
  • Costa Rica
  • Cote d'Ivoire
  • Croatia
  • Cuba
  • Curacao
  • Cyprus
  • Czech Republic
  • Denmark
  • Djibouti
  • Dominica
  • Dominican Republic
  • Ecuador
  • Egypt
  • El Salvador
  • England
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • European Union
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Global
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and McDonald Islands
  • Holy See
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran, Islamic Republic of
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jersey
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea, Democratic People's Republic of
  • Korea, Republic of
  • Kosovo
  • Kurdistan
  • Kuwait
  • Kyrgyzstan
  • Lao People's Democratic Republic
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macao
  • Macedonia, The Former Yugoslav Republic of
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia, Federated States of
  • Moldova, Republic of
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Territory, Occupied
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russian Federation
  • Rwanda
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Scotland
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • Somaliland
  • South Africa
  • South Georgia and the South Sandwich Islands
  • South Sudan
  • Spain
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Taiwan, Province of China
  • Tajikistan
  • Tanzania
  • Thailand
  • Tibet
  • Timor-Leste
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Venezuela, Bolivarian Republic of
  • Viet Nam
  • Virgin Islands, British
  • Virgin Islands, U.S.
  • Wales
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zanzibar
  • Zimbabwe
Show More

Publishers

  • HJ Research
  • XYZ Research
  • Grace Market Data
  • Hey Report
  • MAResearch
  • HNY Research
  • Prof Research
  • ABR Reports
Show More
  • Asia Pacific Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity

    Asia Pacific wireless healthcare market will grow by 27.6% over 2020-2026 with a total addressable market cap of $382.3 billion driven by the rising healthcare expenditure and need for advanced solutions in the region.
    Highlighted with 33 tables and 51 figures, this 114-page report “Asia Pacific Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific wireless healthcare market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with historic study covering 2015-2019 and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia Pacific wireless healthcare market in every aspect of the classification from perspectives of Component, Device, Technology, Application, End User, and Country.
    Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Hardware
    • Software
    • Service
    Based on Device, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Tablet PC
    • Smartphone
    • Mobile Phone
    • Pager
    • PDA
    Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    WPAN
    • RFID, RTLS, and IPS
    • Bluetooth
    • Ant+
    • Ultra-wide Band (UWB)
    • ZigBee
    • Z-wave
    WWAN
    • 3G and 4G
    • CDMA
    • GPRS
    • GPS
    WLAN/Wi-Fi
    WiMAX
    Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Healthcare Amenities
    • Home Care
    • Pharmaceuticals
    • Physicians
    • Telehealth
    • Medical & Diagnostic Laboratories
    • Other Applications
    Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Patients/Individuals
    • Payers
    • Providers
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • Japan
    • China
    • South Korea
    • Australia
    • India
    • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    For each of the five key countries, market analysis and revenue data are available for 2015-2026. The breakdown of major national markets by Device, Technology, and Application over the years 2015-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Asia Pacific wireless healthcare market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Aerohive Networks, Inc.
    Alcatel-Lucent
    Allscripts Healthcare Solutions, Inc.
    Apple, Inc.
    AT&T, Inc.
    Cerner Corporation
    Cisco Systems, Inc.
    GE Healthcare
    Mckesson Corporation
    Motorola Solutions, Inc.
    Nihon Kohden Corporation
    Omron Corporation
    Philips Healthcare
    Polar Electro Inc.
    Qualcomm, Inc.
    Samsung Electronics Co. Ltd
    Siemens A.G.
    Verizon Communications, Inc.
    Vocera Communication, Inc.
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Europe Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity

    Europe wireless healthcare market was valued at $23.51 billion in 2019 and will grow by 24.5% over 2020-2026 owing to the rising healthcare expenditure and need for advanced solutions in the region.
    Highlighted with 36 tables and 52 figures, this 115-page report “Europe Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe wireless healthcare market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with historic study covering 2015-2019 and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Europe wireless healthcare market in every aspect of the classification from perspectives of Component, Device, Technology, Application, End User, and Country.
    Based on Component, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Hardware
    • Software
    • Service
    Based on Device, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Tablet PC
    • Smartphone
    • Mobile Phone
    • Pager
    • PDA
    Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    WPAN
    • RFID, RTLS, and IPS
    • Bluetooth
    • Ant+
    • Ultra-wide Band (UWB)
    • ZigBee
    • Z-wave
    WWAN
    • 3G and 4G
    • CDMA
    • GPRS
    • GPS
    WLAN/Wi-Fi
    WiMAX
    Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Healthcare Amenities
    • Home Care
    • Pharmaceuticals
    • Physicians
    • Telehealth
    • Medical & Diagnostic Laboratories
    • Other Applications
    Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Patients/Individuals
    • Payers
    • Providers
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    For each of the five key countries, market analysis and revenue data are available for 2015-2026. The breakdown of major national markets by Device, Technology, and Application over the years 2015-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Europe wireless healthcare market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Aerohive Networks, Inc.
    Alcatel-Lucent
    Allscripts Healthcare Solutions, Inc.
    Apple, Inc.
    AT&T, Inc.
    Cerner Corporation
    Cisco Systems, Inc.
    GE Healthcare
    Mckesson Corporation
    Motorola Solutions, Inc.
    Nihon Kohden Corporation
    Omron Corporation
    Philips Healthcare
    Polar Electro Inc.
    Qualcomm, Inc.
    Samsung Electronics Co. Ltd
    Siemens A.G.
    Verizon Communications, Inc.
    Vocera Communication, Inc.
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • North America Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity

    North America wireless healthcare market is expected to grow by 22.0% annually in the forecast period and reach $103.02 billion by 2026.
    Highlighted with 26 tables and 48 figures, this 109-page report “North America Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America wireless healthcare market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with historic study covering 2015-2019 and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify North America wireless healthcare market in every aspect of the classification from perspectives of Component, Device, Technology, Application, End User, and Country.
    Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Hardware
    • Software
    • Service
    Based on Device, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Tablet PC
    • Smartphone
    • Mobile Phone
    • Pager
    • PDA
    Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    WPAN
    • RFID, RTLS, and IPS
    • Bluetooth
    • Ant+
    • Ultra-wide Band (UWB)
    • ZigBee
    • Z-wave
    WWAN
    • 3G and 4G
    • CDMA
    • GPRS
    • GPS
    WLAN/Wi-Fi
    WiMAX
    Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Healthcare Amenities
    • Home Care
    • Pharmaceuticals
    • Physicians
    • Telehealth
    • Medical & Diagnostic Laboratories
    • Other Applications
    Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Patients/Individuals
    • Payers
    • Providers
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • U.S.
    • Canada
    • Mexico
    For each of the aforementioned countries, market analysis and revenue data are available for 2015-2026. The breakdown of major national markets by Device, Technology, and Application over the years 2015-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in North America wireless healthcare market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Aerohive Networks, Inc.
    Alcatel-Lucent
    Allscripts Healthcare Solutions, Inc.
    Apple, Inc.
    AT&T, Inc.
    Cerner Corporation
    Cisco Systems, Inc.
    GE Healthcare
    Mckesson Corporation
    Motorola Solutions, Inc.
    Nihon Kohden Corporation
    Omron Corporation
    Philips Healthcare
    Polar Electro Inc.
    Qualcomm, Inc.
    Samsung Electronics Co. Ltd
    Siemens A.G.
    Verizon Communications, Inc.
    Vocera Communication, Inc.
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Global Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity

    Global wireless healthcare market is expected to reach $362.5 billion by 2026, representing a 2020-2026 CAGR of 24.2%.
    Highlighted with 86 tables and 85 figures, this 169-page report “Global Wireless Healthcare Market 2020-2026 by Component, Device, Technology, Application, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global wireless healthcare market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global wireless healthcare market in every aspect of the classification from perspectives of Component, Device, Technology, Application, End User, and Region.
    Based on Component, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Hardware
    • Software
    • Service
    Based on Device, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Tablet PC
    • Smartphone
    • Mobile Phone
    • Pager
    • PDA
    Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    WPAN
    • RFID, RTLS, and IPS
    • Bluetooth
    • Ant+
    • Ultra-wide Band (UWB)
    • ZigBee
    • Z-wave
    WWAN
    • 3G and 4G
    • CDMA
    • GPRS
    • GPS
    WLAN/Wi-Fi
    WiMAX
    Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Healthcare Amenities
    • Home Care
    • Pharmaceuticals
    • Physicians
    • Telehealth
    • Medical & Diagnostic Laboratories
    • Other Applications
    Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2015-2026 included in each section.
    • Patients/Individuals
    • Payers
    • Providers
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into The Netherlands, Denmark, Austria, Norway, Sweden, Belgium, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    • North America (U.S., Canada, and Mexico)
    • South America (Brazil, Columbia, Argentina, Rest of Latin America)
    • RoW (Saudi Arabia, UAE, Egypt)
    For each of the aforementioned regions and countries, market analysis and revenue data are available for 2015-2026. The breakdown of all regional markets by country and split of major national markets by Device, Technology, and Application over the years 2015-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in global wireless healthcare market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Aerohive Networks, Inc.
    Alcatel-Lucent
    Allscripts Healthcare Solutions, Inc.
    Apple, Inc.
    AT&T, Inc.
    Cerner Corporation
    Cisco Systems, Inc.
    GE Healthcare
    Mckesson Corporation
    Motorola Solutions, Inc.
    Nihon Kohden Corporation
    Omron Corporation
    Philips Healthcare
    Polar Electro Inc.
    Qualcomm, Inc.
    Samsung Electronics Co. Ltd
    Siemens A.G.
    Verizon Communications, Inc.
    Vocera Communication, Inc.
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Asia Pacific Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

    Asia Pacific wireless electrocardiography market will grow by 8.06% over 2020-2026 with a total addressable market cap of $2.19 billion driven by the rising healthcare expenditure and growing need for ECG devices in the region.
    Highlighted with 32 tables and 36 figures, this 101-page report “Asia Pacific Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific wireless electrocardiography market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia Pacific wireless electrocardiography market in every aspect of the classification from perspectives of Product Type, Device Modality, End User, Distribution Channel, and Country.
    Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    Monitoring ECG Systems
    • Remote Data Monitoring
    • Event Monitoring
    • Continuous Cardiovascular Monitoring Systems
    Diagnostic ECG Systems
    • Rest ECG Systems
    • Stress ECG Systems
    • Holter ECG Systems
    Based on Device Modality, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Handheld Device
    • Pen
    • Band
    Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Home-based Users
    • Hospitals
    • Clinics
    • Ambulatory Services
    • Other End Users
    Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • E-commerce
    • Offline Sales
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • Japan
    • China
    • South Korea
    • Australia
    • India
    • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    For each of the five key countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Device Modality, and End User over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Asia Pacific wireless electrocardiography market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Abbott
    Aerotel Medical Systems
    AliveCor
    Becton Dickinson
    BPL Medical Technologies
    Cardiocity Limited
    CardioComm Solutions
    GE Healthcare
    iRhythm Technologies
    Johnson & Johnson
    MD Biomedical, Inc.
    MediBioSense
    Medtronic
    Nihon Kohden
    Omron Healthcare
    Philips Healthcare
    Thermo Fisher Scientific
    Thor Laboratories
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Europe Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

    Europe wireless electrocardiography market reached $448.3 million in 2019 and will grow by 5.87% over 2020-2026 owing to the rising need for ECG devices in the region.
    Highlighted with 32 tables and 36 figures, this 100-page report “Europe Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe wireless electrocardiography market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Europe wireless electrocardiography market in every aspect of the classification from perspectives of Product Type, Device Modality, End User, Distribution Channel, and Country.
    Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    Monitoring ECG Systems
    • Remote Data Monitoring
    • Event Monitoring
    • Continuous Cardiovascular Monitoring Systems
    Diagnostic ECG Systems
    • Rest ECG Systems
    • Stress ECG Systems
    • Holter ECG Systems
    Based on Device Modality, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Handheld Device
    • Pen
    • Band
    Based on End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Home-based Users
    • Hospitals
    • Clinics
    • Ambulatory Services
    • Other End Users
    Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • E-commerce
    • Offline Sales
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe (further segmented into Russia, Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    For each of the five key countries, market analysis and revenue data are available for 2019-2026. The breakdown of major national markets by Product Type, Device Modality, and End User over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Europe wireless electrocardiography market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Abbott
    Aerotel Medical Systems
    AliveCor
    Becton Dickinson
    BPL Medical Technologies
    Cardiocity Limited
    CardioComm Solutions
    GE Healthcare
    iRhythm Technologies
    Johnson & Johnson
    MD Biomedical, Inc.
    MediBioSense
    Medtronic
    Nihon Kohden
    Omron Healthcare
    Philips Healthcare
    Thermo Fisher Scientific
    Thor Laboratories
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • North America Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity

    North America wireless electrocardiography market is expected to grow by 5.75% annually in the forecast period and reach $950.3 million by 2026.
    Highlighted with 25 tables and 33 figures, this 97-page report “North America Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America wireless electrocardiography market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify North America wireless electrocardiography market in every aspect of the classification from perspectives of Product Type, Device Modality, End User, Distribution Channel, and Country.
    Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    Monitoring ECG Systems
    • Remote Data Monitoring
    • Event Monitoring
    • Continuous Cardiovascular Monitoring Systems
    Diagnostic ECG Systems
    • Rest ECG Systems
    • Stress ECG Systems
    • Holter ECG Systems
    Based on Device Modality, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Handheld Device
    • Pen
    • Band
    Based on End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Home-based Users
    • Hospitals
    • Clinics
    • Ambulatory Services
    • Other End Users
    Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • E-commerce
    • Offline Sales
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • U.S.
    • Canada
    • Mexico
    For each of the aforementioned countries, market analysis and revenue data are available for 2019-2026. The breakdown of all regional markets by country and split of major national markets by Product Type, Device Modality, and End User over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in North America wireless electrocardiography market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Abbott
    Aerotel Medical Systems
    AliveCor
    Becton Dickinson
    BPL Medical Technologies
    Cardiocity Limited
    CardioComm Solutions
    GE Healthcare
    iRhythm Technologies
    Johnson & Johnson
    MD Biomedical, Inc.
    MediBioSense
    Medtronic
    Nihon Kohden
    Omron Healthcare
    Philips Healthcare
    Thermo Fisher Scientific
    Thor Laboratories
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Global Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity

    Global wireless electrocardiography market is expected to reach $2,276.1 million by 2026, representing a 2020-2026 CAGR of 6.05%.
    Highlighted with 81 tables and 68 figures, this 153-page report “Global Wireless Electrocardiography (ECG) Devices Market 2020-2026 by Product Type, Device Modality, End User, Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global wireless electrocardiography market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global wireless electrocardiography market in every aspect of the classification from perspectives of Product Type, Device Modality, End User, Distribution Channel, and Region.
    Based on Product Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    Monitoring ECG Systems
    • Remote Data Monitoring
    • Event Monitoring
    • Continuous Cardiovascular Monitoring Systems
    Diagnostic ECG Systems
    • Rest ECG Systems
    • Stress ECG Systems
    • Holter ECG Systems
    Based on Device Modality, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Handheld Device
    • Pen
    • Band
    Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Home-based Users
    • Hospitals
    • Clinics
    • Ambulatory Services
    • Other End Users
    Based on Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • E-commerce
    • Offline Sales
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    • Europe (Germany, UK, France, Spain, Italy, Rest of Europe; Rest of Europe is further segmented into Russia, The Netherlands, Denmark, Austria, Norway, Sweden, Belgium, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    • North America (U.S., Canada, and Mexico)
    • South America (Brazil, Chile, Argentina, Rest of Latin America)
    • RoW (Saudi Arabia, UAE, South Africa)
    For each of the aforementioned regions and countries, market analysis and revenue data are available for 2019-2026. The breakdown of all regional markets by country and split of major national markets by Product Type, Device Modality, and End User over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in global wireless electrocardiography market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Abbott
    Aerotel Medical Systems
    AliveCor
    Becton Dickinson
    BPL Medical Technologies
    Cardiocity Limited
    CardioComm Solutions
    GE Healthcare
    iRhythm Technologies
    Johnson & Johnson
    MD Biomedical, Inc.
    MediBioSense
    Medtronic
    Nihon Kohden
    Omron Healthcare
    Philips Healthcare
    Thermo Fisher Scientific
    Thor Laboratories
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Asia Pacific Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country: Trend Forecast and Growth Opportunity

    Asia Pacific medical display market will grow by 6.09% over 2020-2026 with a total addressable market cap of $4.77 billion driven by the rising need for various medical displays in the region.
    Highlighted with 38 tables and 48 figures, this 104-page report “Asia Pacific Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific medical display market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Asia Pacific medical display market in every aspect of the classification from perspectives of Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country.
    Based on Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • LED-backlit LCD
    • CCFL-backlit LCD
    • OLED
    Based on Platform Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Mobile
    • Desktop
    • All-in-One
    Based on Resolution, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Up To 2Mp
    • 2.1Mp-4Mp
    • 4.1Mp-8Mp
    • Above 8Mp
    Based on Display Color, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Colored
    • Monochrome
    Based on Panel Size, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    • Under 22.9 Inches
    • 23.0-26.9 Inches
    • 27.0-41.9 Inches
    • Above 42 Inches
    Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    Diagnostic
    • General Radiology
    • Mammography
    • Digital Pathology
    • Multi-Modality Applications
    Surgical
    Clinical
    Other Applications
    Geographically, the following national/local markets are fully investigated:
    • Japan
    • China
    • South Korea
    • Australia
    • India
    • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    For each of the five key countries, market analysis and revenue/volume data are available for 2019-2026. The breakdown of major national markets by Technology, Resolution, Panel Size, and Application over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Asia Pacific medical display market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Advantech Co. Ltd.
    Barco NV
    EIZO Corporation
    FSN
    Jusha Medical
    JVCKENWOOD Corporation
    LG Display Co. Ltd.
    Novanta Inc.
    Quest International
    Siemens AG
    Sony Corporation
    Steris plc
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Europe Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country: Trend Forecast and Growth Opportunity

    Europe medical display market reached $638.5 million in 2019 and will grow by 4.34% over 2020-2026 owing to the rising need for various medical displays in the region.
    Highlighted with 38 tables and 48 figures, this 103-page report “Europe Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe medical display market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Europe medical display market in every aspect of the classification from perspectives of Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country.
    Based on Technology, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • LED-backlit LCD
    • CCFL-backlit LCD
    • OLED
    Based on Platform Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Mobile
    • Desktop
    • All-in-One
    Based on Resolution, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Up To 2Mp
    • 2.1Mp-4Mp
    • 4.1Mp-8Mp
    • Above 8Mp
    Based on Display Color, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Colored
    • Monochrome
    Based on Panel Size, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    • Under 22.9 Inches
    • 23.0-26.9 Inches
    • 27.0-41.9 Inches
    • Above 42 Inches
    Based on Application, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    Diagnostic
    • General Radiology
    • Mammography
    • Digital Pathology
    • Multi-Modality Applications
    Surgical
    Clinical
    Other Applications
    Geographically, the following national/local markets are fully investigated:
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe (further segmented into Russia, Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    For each of the five key countries, market analysis and revenue/volume data are available for 2019-2026. The breakdown of major national markets by Technology, Resolution, Panel Size, and Application over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Europe medical display market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Advantech Co. Ltd.
    Barco NV
    EIZO Corporation
    FSN
    Jusha Medical
    JVCKENWOOD Corporation
    LG Display Co. Ltd.
    Novanta Inc.
    Quest International
    Siemens AG
    Sony Corporation
    Steris plc
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • North America Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country: Trend Forecast and Growth Opportunity

    North America medical display market is expected to grow by 4.51% annually in the forecast period and reach $1.03 billion by 2026.
    Highlighted with 29 tables and 45 figures, this 97-page report “North America Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America medical display market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify North America medical display market in every aspect of the classification from perspectives of Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Country.
    Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • LED-backlit LCD
    • CCFL-backlit LCD
    • OLED
    Based on Platform Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Mobile
    • Desktop
    • All-in-One
    Based on Resolution, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Up To 2Mp
    • 2.1Mp-4Mp
    • 4.1Mp-8Mp
    • Above 8Mp
    Based on Display Color, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Colored
    • Monochrome
    Based on Panel Size, the North America market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    • Under 22.9 Inches
    • 23.0-26.9 Inches
    • 27.0-41.9 Inches
    • Above 42 Inches
    Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    Diagnostic
    • General Radiology
    • Mammography
    • Digital Pathology
    • Multi-Modality Applications
    Surgical
    Clinical
    Other Applications
    Geographically, the following national/local markets are fully investigated:
    • U.S.
    • Canada
    • Mexico
    For each of the aforementioned countries, market analysis and revenue/volume data are available for 2019-2026. The breakdown of major national markets by Technology, Resolution, Panel Size, and Application over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in North America medical display market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Advantech Co. Ltd.
    Barco NV
    EIZO Corporation
    FSN
    Jusha Medical
    JVCKENWOOD Corporation
    LG Display Co. Ltd.
    Novanta Inc.
    Quest International
    Siemens AG
    Sony Corporation
    Steris plc
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Global Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Region: Trend Forecast and Growth Opportunity

    Global medical display market is expected to reach $2,997.7 million by 2026, representing a 2020-2026 CAGR of 4.87%.
    Highlighted with 101 tables and 80 figures, this 156-page report “Global Medical Display Market 2020-2026 by Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global medical display market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global medical display market in every aspect of the classification from perspectives of Technology, Platform Type, Resolution, Display Color, Panel Size, Application, and Region.
    Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • LED-backlit LCD
    • CCFL-backlit LCD
    • OLED
    Based on Platform Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Mobile
    • Desktop
    • All-in-One
    Based on Resolution, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Up To 2Mp
    • 2.1Mp-4Mp
    • 4.1Mp-8Mp
    • Above 8Mp
    Based on Display Color, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2026 included in each section.
    • Colored
    • Monochrome
    Based on Panel Size, the global market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    • Under 22.9 Inches
    • 23.0-26.9 Inches
    • 27.0-41.9 Inches
    • Above 42 Inches
    Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) 2019-2026 included in each section.
    Diagnostic
    • General Radiology
    • Mammography
    • Digital Pathology
    • Multi-Modality Applications
    Surgical
    Clinical
    Other Applications
    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    • Europe (Germany, UK, France, Spain, Italy, Rest of Europe; Rest of Europe is further segmented into Russia, The Netherlands, Denmark, Austria, Norway, Sweden, Belgium, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    • North America (U.S., Canada, and Mexico)
    • South America (Brazil, Chile, Argentina, Rest of Latin America)
    • RoW (Saudi Arabia, UAE, South Africa)
    For each of the aforementioned regions and countries, market analysis and revenue/volume data are available for 2019-2026. The breakdown of all regional markets by country and split of major national markets by Technology, Resolution, Panel Size, and Application over the years 2019-2026 are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in global medical display market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Advantech Co. Ltd.
    Barco NV
    EIZO Corporation
    FSN
    Jusha Medical
    JVCKENWOOD Corporation
    LG Display Co. Ltd.
    Novanta Inc.
    Quest International
    Siemens AG
    Sony Corporation
    Steris plc
    (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Southeast Asia Nutritional Supplements Market by Ingredient, Product Form, Application, End-user, Supplement Classification, Distribution Channel, and Country 2019-2026: Trend Forecast and Growth Opportunity

    Southeast Asia nutritional supplements market will grow at a 2019-2026 CAGR of 6.6% with a total addressable market of $23.35 billion during the forecast period.
    Highlighted with 51 tables and 58 figures, this 146-page report “Southeast Asia Nutritional Supplements Market by Ingredient, Product Form, Application, End-user, Supplement Classification, Distribution Channel, and Country 2019-2026: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Southeast Asia nutritional supplements market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Southeast Asia market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify Southeast Asia nutritional supplements market in every aspect of the classification from perspectives of Ingredient, Product Form, Application, End-user, Supplement Classification, Distribution Channel, and Country.
    Based on ingredient, the Southeast Asia market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each section.
    • Botanicals
    • Vitamins
    • Minerals
    • Proteins & Amino Acids
    • Fish Oils
    • Fibers & Specialty Carbohydrates
    • Enzymes
    • Others
    Based on product form, the Southeast Asia market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each segment.
    • Tablets
    • Capsules
    • Powder
    • Liquids
    • Soft Gels & Gel Caps
    • Gummies
    • Others
    Based on application, the Southeast Asia market is analyzed on the following segments with annual capex for 2015-2026 (historical and forecast) included in each section.
    • Additional Supplements
    • Medicinal Supplements
    • Sports Nutrition
    Based on end-user, the Southeast Asia market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each section.
    • Infant
    • Children
    • Adults
    • Pregnant Women
    • Elderly
    Based on classification, the Southeast Asia market is segmented into the following sub-markets with annual capex for 2015-2026 (historical and forecast) included in each segment.
    • OTC
    • Prescription
    Based on distribution channel, the Southeast Asia market is analyzed on the following segments with annual capex for 2015-2026 (historical and forecast) included in each section.
    • Retail Stores & Hospitals
    • Supermarkets & Hypermarkets
    • Online Stores
    • Others
    Geographically, the following national markets are fully investigated:
    • Taiwan
    • Hong Kong
    • Indonesia
    • Malaysia
    • Vietnam
    • Thailand
    • Singapore
    • Philippines
    • Rest of Southeast Asia
    For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Ingredient, Product Form, Application, End-user, and Distribution Channel over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Southeast Asia nutritional supplements market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    Abbott Laboratories
    ADM
    American Health
    Amway Corporation
    Archer Daniels Midland Company
    Arkopharma Laboratoires Pharmaceutiques
    Ayanda
    Bayer
    Bionova Lifesciences
    Carlyle Group
    DuPont
    DSM
    Ekomir
    Glanbia Nutritionals
    GlaxoSmithKline
    Herbalife International
    Himalaya Southeast Asia Holdings Ltd.
    Nature’s Sunshine Products
    Nestle Nutritionals
    NBTY, Inc.
    Pfizer Inc.
    Stepan
    XanGo
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Asia Pacific Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

    Asia Pacific active pharmaceutical ingredients (API) market will grow by 9.1% annually with a total addressable market cap of $584.2 billion over 2020-2030 amid the COVID-19 pandemic.
    Highlighted with 38 tables and 65 figures, this 133-page report “Asia Pacific Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

    Based on Synthesis, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Synthetic API
    • Branded Synthetic API
    • Generic Synthetic API
    Biotech API by Drug Type:
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Other Biotech APIs
    Biotech API by Customer Base:
    • Innovative Biologic API
    • Generic Biosimilar API
    Biotech API by Expression Technology:
    • Mammalian Expression
    • Microbial Expression
    • Yeast Expression
    • Insect Expression
    • Other Expression Technologies
    HPAPI
    • Branded HPAPI
    • Generic HPAPI

    Based on Manufacturing Process, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Captive Manufacturing
    • Branded Captive API
    • Generic Captive API
    Merchant Manufacturing by Drug Type:
    • Branded Merchant API
    • Generic Merchant API
    Merchant Manufacturing by Drug Synthesis:
    • Merchant Synthetic API
    • Merchant Biotech API

    Based on Therapeutic Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Infectious Diseases
    • Oncology
    • Ophthalmology
    • Cardiovascular Disorders
    • Central Nervous System
    • Pulmonary Disorders
    • Orthopedics
    • Other Applications

    Based on Drug Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Branded Prescription Drugs
    • Generic Prescription Drugs
    • OTC Drugs

    Geographically, the following national/local markets are fully investigated:
    • Japan
    • China
    • South Korea
    • Australia
    • India
    • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    For each aforementioned country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Asia Pacific API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    AbbVie Inc.
    Astrazeneca
    Aurobindo Pharma Ltd.
    Bayer Healthcare
    Bioniche Animal Health
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Ceva Animal Health, Inc.
    Elanco Animal Health
    Eli Lilly and Company
    F. Hoffmann-La Roche
    Glaxosmithkline PLC
    Heska Co.
    Lonza Group
    Merck & Co., Inc.
    Novartis International AG
    Pfizer, Inc.
    Ranbaxy Laboratories
    Sanofi
    Sun Pharmaceutical Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Europe Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

    Europe active pharmaceutical ingredients (API) market reached $42.41 billion in 2019 and will grow by 7.6% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
    Highlighted with 41 tables and 66 figures, this 133-page report “Europe Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

    Based on Synthesis, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Synthetic API
    • Branded Synthetic API
    • Generic Synthetic API
    Biotech API by Drug Type:
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Other Biotech APIs
    Biotech API by Customer Base:
    • Innovative Biologic API
    • Generic Biosimilar API
    Biotech API by Expression Technology:
    • Mammalian Expression
    • Microbial Expression
    • Yeast Expression
    • Insect Expression
    • Other Expression Technologies
    HPAPI
    • Branded HPAPI
    • Generic HPAPI

    Based on Manufacturing Process, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Captive Manufacturing
    • Branded Captive API
    • Generic Captive API
    Merchant Manufacturing by Drug Type:
    • Branded Merchant API
    • Generic Merchant API
    Merchant Manufacturing by Drug Synthesis:
    • Merchant Synthetic API
    • Merchant Biotech API

    Based on Therapeutic Application, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Infectious Diseases
    • Oncology
    • Ophthalmology
    • Cardiovascular Disorders
    • Central Nervous System
    • Pulmonary Disorders
    • Orthopedics
    • Other Applications

    Based on Drug Type, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Branded Prescription Drugs
    • Generic Prescription Drugs
    • OTC Drugs

    Geographically, the following national/local markets are fully investigated:
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    For each aforementioned country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Europe API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    AbbVie Inc.
    Astrazeneca
    Aurobindo Pharma Ltd.
    Bayer Healthcare
    Bioniche Animal Health
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Ceva Animal Health, Inc.
    Elanco Animal Health
    Eli Lilly and Company
    F. Hoffmann-La Roche
    Glaxosmithkline PLC
    Heska Co.
    Lonza Group
    Merck & Co., Inc.
    Novartis International AG
    Pfizer, Inc.
    Ranbaxy Laboratories
    Sanofi
    Sun Pharmaceutical Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • North America Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity

    North America active pharmaceutical ingredients (API) market is expected to grow by 5.7% annually in the forecast period and reach $101.03 billion by 2026 driven by the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
    Highlighted with 31 tables and 62 figures, this 128-page report “North America Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Country.

    Based on Synthesis, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Synthetic API
    • Branded Synthetic API
    • Generic Synthetic API
    Biotech API by Drug Type:
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Other Biotech APIs
    Biotech API by Customer Base:
    • Innovative Biologic API
    • Generic Biosimilar API
    Biotech API by Expression Technology:
    • Mammalian Expression
    • Microbial Expression
    • Yeast Expression
    • Insect Expression
    • Other Expression Technologies
    HPAPI
    • Branded HPAPI
    • Generic HPAPI

    Based on Manufacturing Process, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Captive Manufacturing
    • Branded Captive API
    • Generic Captive API
    Merchant Manufacturing by Drug Type:
    • Branded Merchant API
    • Generic Merchant API
    Merchant Manufacturing by Drug Synthesis:
    • Merchant Synthetic API
    • Merchant Biotech API

    Based on Therapeutic Application, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Infectious Diseases
    • Oncology
    • Ophthalmology
    • Cardiovascular Disorders
    • Central Nervous System
    • Pulmonary Disorders
    • Orthopedics
    • Other Applications

    Based on Drug Type, the North America market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Branded Prescription Drugs
    • Generic Prescription Drugs
    • OTC Drugs

    Geographically, the following national/local markets are fully investigated:
    • U.S.
    • Canada
    • Mexico
    For each aforementioned country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in North America API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    AbbVie Inc.
    Astrazeneca
    Aurobindo Pharma Ltd.
    Bayer Healthcare
    Bioniche Animal Health
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Ceva Animal Health, Inc.
    Elanco Animal Health
    Eli Lilly and Company
    F. Hoffmann-La Roche
    Glaxosmithkline PLC
    Heska Co.
    Lonza Group
    Merck & Co., Inc.
    Novartis International AG
    Pfizer, Inc.
    Ranbaxy Laboratories
    Sanofi
    Sun Pharmaceutical Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

    Global active pharmaceutical ingredients (API) market will reach $293.5 billion by 2026, growing by 7.2% annually over 2020-2026 owing to the rising need for medicine and pharmaceutical agents amid the COVID-19 pandemic.
    Highlighted with 91 tables and 99 figures, this 190-page report “Global Active Pharmaceutical Ingredients (API) Market 2020-2026 by Synthesis (Synthetic, Biotech, HPAPI), Manufacturing Process (Captive, Merchant), Therapeutic Application, Drug Type, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2026 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global API market in every aspect of the classification from perspectives of Synthesis, Manufacturing Process, Therapeutic Application, Drug Type, and Region.

    Based on Synthesis, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Synthetic API
    • Branded Synthetic API
    • Generic Synthetic API
    Biotech API by Drug Type:
    • Monoclonal Antibodies
    • Recombinant Proteins
    • Vaccines
    • Other Biotech APIs
    Biotech API by Customer Base:
    • Innovative Biologic API
    • Generic Biosimilar API
    Biotech API by Expression Technology:
    • Mammalian Expression
    • Microbial Expression
    • Yeast Expression
    • Insect Expression
    • Other Expression Technologies
    HPAPI
    • Branded HPAPI
    • Generic HPAPI

    Based on Manufacturing Process, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    Captive Manufacturing
    • Branded Captive API
    • Generic Captive API
    Merchant Manufacturing by Drug Type:
    • Branded Merchant API
    • Generic Merchant API
    Merchant Manufacturing by Drug Synthesis:
    • Merchant Synthetic API
    • Merchant Biotech API

    Based on Therapeutic Application, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Infectious Diseases
    • Oncology
    • Ophthalmology
    • Cardiovascular Disorders
    • Central Nervous System
    • Pulmonary Disorders
    • Orthopedics
    • Other Applications

    Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2015-2026 included in each section.
    • Branded Prescription Drugs
    • Generic Prescription Drugs
    • OTC Drugs

    Geographically, the following regions together with the listed national/local markets are fully investigated:
    • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    • North America (U.S., Canada, and Mexico)
    • South America (Brazil, Chile, Argentina, Rest of South America)
    • RoW (Saudi Arabia, UAE, South Africa)
    For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of all regional markets by country and split of key national markets by Synthesis, Manufacturing Process, and Therapeutic Application over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in global API market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    AbbVie Inc.
    Astrazeneca
    Aurobindo Pharma Ltd.
    Bayer Healthcare
    Bioniche Animal Health
    Boehringer Ingelheim
    Bristol-Myers Squibb
    Ceva Animal Health, Inc.
    Elanco Animal Health
    Eli Lilly and Company
    F. Hoffmann-La Roche
    Glaxosmithkline PLC
    Heska Co.
    Lonza Group
    Merck & Co., Inc.
    Novartis International AG
    Pfizer, Inc.
    Ranbaxy Laboratories
    Sanofi
    Sun Pharmaceutical Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

    Asia Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of $219.0 million over 2020-2030 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
    Highlighted with 31 tables and 42 figures, this 104-page report “Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

    Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    Therapeutic Devices
    • Inhalers
    • Nebulizers
    Diagnostic Devices
    • Spirometers
    • Asthma Monitors
    • Other Diagnostic Devices
    Sensors and Apps

    Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19 Caused Diseases
    • Other Diseases

    Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

    Geographically, the following national/local markets are fully investigated:
    • Japan
    • China
    • South Korea
    • Australia
    • India
    • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
    For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Asia Pacific digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    3M Health Care Limited
    Adherium Limited
    Amiko Digital Health Limited
    AsthmaMD
    AstraZeneca plc
    Boehringer Ingelheim International GmbH
    Capsule Technologies, Inc.
    Cohero Health
    GlaxoSmithKline plc
    Kaia Health Software GmbH
    Medical International Research (MIR)
    Novartis AG
    NuvoAir
    Reciprocal Labs (Propeller Health)
    Sensiron AG
    Tactio Health
    Teva Pharmaceuticals Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
  • Europe Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

    Europe digital respiratory solutions market reached $2.75 million in 2019 and will grow by 35.9% annually over 2020-2026 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
    Highlighted with 34 tables and 43 figures, this 106-page report “Europe Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

    Based on Product Type, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    Therapeutic Devices
    • Inhalers
    • Nebulizers
    Diagnostic Devices
    • Spirometers
    • Asthma Monitors
    • Other Diagnostic Devices
    Sensors and Apps

    Based on Indication, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19 Caused Diseases
    • Other Diseases

    Based on Distribution Channel, the Europe market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

    Geographically, the following national/local markets are fully investigated:
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
    For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in Europe digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    3M Health Care Limited
    Adherium Limited
    Amiko Digital Health Limited
    AsthmaMD
    AstraZeneca plc
    Boehringer Ingelheim International GmbH
    Capsule Technologies, Inc.
    Cohero Health
    GlaxoSmithKline plc
    Kaia Health Software GmbH
    Medical International Research (MIR)
    Novartis AG
    NuvoAir
    Reciprocal Labs (Propeller Health)
    Sensiron AG
    Tactio Health
    Teva Pharmaceuticals Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

  • North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

    North America digital respiratory solutions market is expected to grow by 34.4% annually in the forecast period and reach $155.05 million by 2030 driven by the rising demand for respiratory aids and air purification amid COVID-19 pandemic.
    Highlighted with 24 tables and 39 figures, this 98-page report “North America Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
    In-depth qualitative analyses include identification and investigation of the following aspects:
    • Market Structure
    • Growth Drivers
    • Restraints and Challenges
    • Emerging Product Trends & Market Opportunities
    • Porter’s Fiver Forces
    The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country.

    Based on Product Type, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    Therapeutic Devices
    • Inhalers
    • Nebulizers
    Diagnostic Devices
    • Spirometers
    • Asthma Monitors
    • Other Diagnostic Devices
    Sensors and Apps

    Based on Indication, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    • Asthma
    • Chronic Obstructive Pulmonary Disease (COPD)
    • COVID-19 Caused Diseases
    • Other Diseases

    Based on Distribution Channel, the North America market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

    Geographically, the following national/local markets are fully investigated:
    • U.S.
    • Canada
    • Mexico
    For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included.
    The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
    Specifically, potential risks associated with investing in North America digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
    Key Players (this may not be a complete list and extra companies can be added upon request):
    3M Health Care Limited
    Adherium Limited
    Amiko Digital Health Limited
    AsthmaMD
    AstraZeneca plc
    Boehringer Ingelheim International GmbH
    Capsule Technologies, Inc.
    Cohero Health
    GlaxoSmithKline plc
    Kaia Health Software GmbH
    Medical International Research (MIR)
    Novartis AG
    NuvoAir
    Reciprocal Labs (Propeller Health)
    Sensiron AG
    Tactio Health
    Teva Pharmaceuticals Industries Ltd.
    (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Newsletters Signup

Sign up to Our Newsletter & get attractive Offers by subscribing to our newsletters.

Thank you for suscrbing!